Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the comparative efficacy and safety of two oral
regimens of dabigatran etexilate, compared to a standard subcutaneous regimen of enoxaparin,
in prevention of venous thromboembolism in patients with primary elective total hip
replacement surgery.